Clinical trial

Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial…

NCT00145106 · KGL, Inc., Other · Completed

Key facts

NCT number NCT00145106
Title Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris
Official title Regimen of Tazorac .1% Gel & Minocycline Cap in Tx of Individuals w/Acne Vulgaris: Effects of Maintenance Therapy on Duration of Improvement of Tazorac .1% Gel Used in Conjunction w/Placebo Cap Compared w/Minocycline Cap Used in Conjunction w/Either Tazorac .1% Gel or Vehicle Gel
Lead sponsor KGL, Inc., Other
Collaborators Milton S. Hershey Medical Center State University of New York - Downstate Medical Center Jefferson Medical College of Thomas Jefferson University NYU Langone Health Allergan Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Acne Vulgaris
Intervention type Drug
Interventions Tazarotene 0.1% gel + placebo capsule, Oral minocycline (100 mg capsule) + vehicle gel, Tazarotene 0.1% gel + oral minocycline (100 mg capsule)
Enrollment 189
Start date Mar 1, 2002
Completion Aug 1, 2002
First posted Sep 5, 2005
Last update posted Dec 15, 2005
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies